LABORATORY EXAMINATION OF HEMOLYTIC DISEASE IN NEONATES DUE TO RHESUS INCOMPATIBILITY

Authors

  • Danny Ernest Jonas Luhulima Faculty of Medicine, Universitas Kristen Indonesia, Jakarta, Indonesia
  • Christian Ronald Tanggo Faculty of Medicine, Universitas Kristen Indonesia, Jakarta, Indonesia
  • Ria Amelia Sekolah Tinggi Ilmu Kesehatan Mitra Keluarga, Bekasi, Indonesia

Keywords:

Neonatus, Hemolytic, Rhesus

Abstract

Hemolytic disease of the newborn (HDN) occurs when fetal red blood cells (RBCs), which possess an antigen that the mother lacks, cross the placenta into the maternal circulation, where they stimulate antibody production. The antibodies return to the fetal circulation and result in RBC destruction. Three classifications of HDN are: ABO, other causes like unexpected immune antibodies like anti-c or anti-K and Rhesus–anti D alone or may be accompanied by other Rh antibodies, examples anti-D with anti-C or anti-E. Clinical presentation of HDN varies from mild jaundice and anemia to hydrops fetalis (with ascites, pleural and pericardial effusions). This article discusses hemolytic due to incompability Rhesus anti-D.)

References

American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. (2004). Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 114(1), 297-316.

De Haas, M., Thurik, F. F., Koelewijn, J. M., & van der Schoot, C. E. (2015). Haemolytic disease of the fetus and newborn. Vox sanguinis, 109(2), 99-113.

Delaney, M., & Matthews, D. C. (2015). Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn. Hematology 2014, the American Society of Hematology Education Program Book, 2015(1), 146-151.

Fasano, R. M. (2016, February). Hemolytic disease of the fetus and newborn in the molecular era. In Seminars in Fetal and Neonatal Medicine (Vol. 21, No. 1, pp. 28-34). WB Saunders.

Luhulima, D. E. J. (2021). Pemeriksaan Laboratorium Penyakit Hemolisis pada Neonatus Akibat Inkompatibilitas Rhesus.

Melanie SK, Hemolytic disease of the newborn and fetus; Chapter 20; in Harmening DM (eds); Modern blood blanking and transfusion practices; Fourth edition; Bangkok Thailand; Book promotion and service Co. LTD; 1994; 421–433.

Nadeak, B., Manik, J., & Destine, D. (2025). The Effectiveness of Managerial Approaches in Promoting Adolescent Healthy Lifestyles: A Qualitative Study at HKBP Gedong Church. Asian Journal of Basic Science & Research, 7(2), 119-128.

Santavy, J. (2010). Hemolytic disease in the newborn–history and prevention in the World and the Czech Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 154(2), 147-151.

Sheth, S. “Hemolytic Diseases of the Newborn.” Dalam Neonatology, disunting oleh Richard A. Polin dan John M. Lorenz, 401–404. Cambridge: Cambridge University Press, 2008. https://doi.org/10.1017/CBO9780511547270.039

Wibowo, H., S. Nurrahmah, dan R.S.E. Gantini. “Maternal IgG in Hemolytic Disease of the Fetus and Newborn–ABO Incompatibility.” Medical Journal of Indonesia 33, no. 2 (2024): 70–74.

Downloads

Published

2026-01-03

How to Cite

Danny Ernest Jonas Luhulima, Christian Ronald Tanggo, & Ria Amelia. (2026). LABORATORY EXAMINATION OF HEMOLYTIC DISEASE IN NEONATES DUE TO RHESUS INCOMPATIBILITY. Journal of Innovation Research and Knowledge, 5(8), 9111–9116. Retrieved from https://mail.bajangjournal.com/index.php/JIRK/article/view/12103